On July 13, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine, adjuvanted for the prevention of COVID-19 caused by severe acute […]
On July 13, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for the Novavax COVID-19 vaccine, adjuvanted for the prevention of COVID-19 caused by severe acute […]
Our Weekly provides insights on local and national news, culture, and lifestyle, from people who know your community best.
We'll send a verification code to %EMAIL%.